SignaBlok awarded NHLBI / NIH SBIR Phase I grant to develop TREM-1 therapy for the treatment of empyema

SignaBlok > News > SignaBlok awarded NHLBI / NIH SBIR Phase I grant to develop TREM-1 therapy for the treatment of empyema

SignaBlok > News > SignaBlok awarded NHLBI / NIH SBIR Phase I grant to develop TREM-1 therapy for the treatment of empyema

SignaBlok awarded NHLBI / NIH SBIR Phase I grant to develop TREM-1 therapy for the treatment of empyema

Vera

View posts by Vera